A collection of articles that provide insights into the power of psychedelic healthcare.
The OHA has released the final rules for Oregon's Psilocybin Services Program. Interested in facilitating psychedelic services? Here's what you need to know.
Read postWhy a data-driven treatment model is the necessary missing piece for scaling psychedelic healthcare safely
Read postWe cover the groundbreaking results from a study about at-home, sublingual Ketamine therapy, its implications for future research, and what its critics say.
Read postAn in-depth answer to the question, “How long does Ketamine last?” and how maintenance and integration therapy deepen & sustain its therapeutic effects.
Read postA guide to Ketamine for autism, anxiety, alcohol use disorder, and other conditions: Why Ketamine works across diagnoses and how it may transform psychiatry.
Read postHakomi therapy is a body-centered modality that honors the goals of psychedelic therapy while also complementing the subjective effects of psychedelics.
Read postHow psychedelic-assisted group therapy answers key logistical and therapeutic questions important for safely implementing and scaling psychedelic medicine.
Read postA guide to psilocybin therapy and the brain, its history in psychiatry, and the challenges standing before its integration into mental healthcare.
Read postKetamine therapy brings relief to those unable to find it in conventional psychiatry. Yet questions about how to best integrate it within mental health care remain.
Read post
